These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38993660)

  • 21. Pharmacokinetic drug evaluation of paliperidone in the treatment of schizoaffective disorder.
    Macaluso M; Oliver H; Sohail Z
    Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):871-879. PubMed ID: 28675307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute agranulocytosis when switching from risperidone to paliperidone.
    Wakuda T; Suzuki A; Hasegawa M; Ichikawa D; Yamasue H
    Aust N Z J Psychiatry; 2019 Jun; 53(6):586-587. PubMed ID: 30636434
    [No Abstract]   [Full Text] [Related]  

  • 23. Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation.
    Mauri MC; Reggiori A; Paletta S; Di Pace C; Altamura AC
    Expert Opin Drug Saf; 2017 Mar; 16(3):365-379. PubMed ID: 28140680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solubilized delivery of paliperidone palmitate by D-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management.
    Muthu MS; Sahu AK; Sonali ; Abdulla A; Kaklotar D; Rajesh CV; Singh S; Pandey BL
    Drug Deliv; 2016; 23(1):230-7. PubMed ID: 24853962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paliperidone-induced dystonic Dysphagia.
    Mendhekar DN; Agarwal A
    J Neuropsychiatry Clin Neurosci; 2010; 22(4):451-v.e37-451.e37. PubMed ID: 21037154
    [No Abstract]   [Full Text] [Related]  

  • 26. Mortality rate is associated with paliperidone palmitate, risperidone long-acting injection, and oral paliperidone administration.
    Suzuki H; Hibino H; Inoue Y; Takaya A
    Asian J Psychiatr; 2018 Jun; 35():28. PubMed ID: 29751217
    [No Abstract]   [Full Text] [Related]  

  • 27. Paliperidone-Associated Atrioventricular Block.
    Yasin M; Lateef N; Pervaiz MH
    Am J Ther; 2018; 25(6):e730-e732. PubMed ID: 29528883
    [No Abstract]   [Full Text] [Related]  

  • 28. Need for Bioequivalence Standards that Reflect the Clinical Importance of the Complex Pharmacokinetics of Paliperidone Palmitate Long-Acting Injectable Suspension.
    Procyshyn RM; Lamoure JW; Katzman MA; Skinner PL; Sherman SE
    J Pharm Pharm Sci; 2019; 22(1):548-566. PubMed ID: 31730504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperprolactinemia in psychotic patients treated in monotherapy with long-acting injectable antipsychotics.
    Bonete Llácer JM; Martínez Hortelano A; Richart Albelda B
    Int J Psychiatry Clin Pract; 2019 Sep; 23(3):189-193. PubMed ID: 30848967
    [No Abstract]   [Full Text] [Related]  

  • 30. Paliperidone-Induced Hyponatremia.
    Tibrewal P; Dhillon R; Sharma J; Bastiampillai T
    Prim Care Companion CNS Disord; 2017 Jul; 19(4):. PubMed ID: 28767207
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum Concentration of Paliperidone Palmitate Administered Every 3 Weeks.
    Cohen JY; Dumoulin-Charette A; Meraabi N; Poirier R
    Psychopharmacol Bull; 2019 Jun; 49(2):57-62. PubMed ID: 31308584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clozapine withdrawal-emergent dystonias and dyskinesias: a case series.
    Ahmed S; Chengappa KN; Naidu VR; Baker RW; Parepally H; Schooler NR
    J Clin Psychiatry; 1998 Sep; 59(9):472-7. PubMed ID: 9771818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement.
    Muser E; Kozma CM; Benson CJ; Mao L; Starr HL; Alphs L; Fastenau J
    J Med Econ; 2015; 18(8):637-45. PubMed ID: 25851616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of paliperidone extended release in adolescents with schizophrenia: a randomized, double-blind study.
    Savitz AJ; Lane R; Nuamah I; Gopal S; Hough D
    J Am Acad Child Adolesc Psychiatry; 2015 Feb; 54(2):126-137.e1. PubMed ID: 25617253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The preclinical discovery and development of paliperidone for the treatment of schizophrenia.
    Wesołowska A; Jastrzębska-Więsek M; Cios A; Partyka A
    Expert Opin Drug Discov; 2020 Mar; 15(3):279-292. PubMed ID: 31661992
    [No Abstract]   [Full Text] [Related]  

  • 36. Risperidone is not only a prodrug: psychosis induced by medication switch from risperidone to paliperidone - a case report.
    Dagenais-Beaulé V
    Eur J Hosp Pharm; 2023 Jul; 30(4):e20. PubMed ID: 34785566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-Dependent Paliperidone Associated With Angioedema.
    Yucel A; Yucel N; Ozcan H; Saritemur M
    J Clin Psychopharmacol; 2015 Oct; 35(5):615-6. PubMed ID: 26125544
    [No Abstract]   [Full Text] [Related]  

  • 38. Hospitalizations and economic analysis in psychotic patients with paliperidone palmitate long-acting injection.
    Mesones-Peral JE; Gurillo-Muñoz P; Sánchez-Sicilia MP; Miller A; Griñant-Fernández A
    Rev Psiquiatr Salud Ment; 2017; 10(1):33-37. PubMed ID: 27053545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can a 4-Month Tolerability Assessment With Paliperidone Palmitate 1-Monthly Prevent Neuroleptic Malignant Syndrome Associated With the 3-Monthly?: Analysis Based on a Spontaneous Reporting System Database in Japan.
    Misawa F; Fujii Y; Takeuchi H
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):206-207. PubMed ID: 33538535
    [No Abstract]   [Full Text] [Related]  

  • 40. The Delirium Related to Oral Paliperidone in Dementia: A Case Report.
    Tsai MC; Chang PT; Yang CH; Liu ME
    J Clin Psychopharmacol; 2016 Apr; 36(2):184-5. PubMed ID: 26872118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.